142465-11-0Relevant articles and documents
SUBSTITUED 3,4-DIHYDROTHIENO [2,3-D] PYRMIDINES AS TISSUE TRANSGLUTAMINASE INHIBITORS
-
Page/Page column 69-70, (2010/11/08)
The present invention provides novel compounds and methods useful for treating transglutaminase associated disorders such as celiac spru, Alzheimer's disease and Huntington's disease. Certain compounds of the invention are tissue transglutaminase inhibito
Synthesis of some triazolothienopyrimidin-5(4H)-ones
Pathak, U S,Gandhi, N V,Singh, S,Warde, R P,Jain, K S
, p. 223 - 229 (2007/10/02)
A series of hitherto unreported 1-(un)substituted-4-phenyltriazolothienopyrimidin-5(4H)-ones (8a-k) have been synthesized by the condensation of 2-hydrazino-3-phenylthienopyrimidin-4(3H)-ones (7a,b) with various one-carbon dono